Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy

MLA

John Fetse, et al. “Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.” Journal of Medicinal Chemistry, vol. 65, Sept. 2022, pp. 12002–13. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c00539.

APA

John Fetse, Zhen Zhao, Hao Liu, Umar-Farouk Mamani, Bahaa Mustafa, Pratik Adhikary, Mohammed Ibrahim, Yanli Liu, Pratikkumar Patel, Maryam Nakhjiri, Mohammed Alahmari, Guangfu Li, & Kun Cheng. (2022). Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy. Journal of Medicinal Chemistry, 65, 12002–12013. https://doi.org/10.1021/acs.jmedchem.2c00539

Chicago

John Fetse, Zhen Zhao, Hao Liu, Umar-Farouk Mamani, Bahaa Mustafa, Pratik Adhikary, Mohammed Ibrahim, et al. 2022. “Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.” Journal of Medicinal Chemistry 65 (September): 12002–13. doi:10.1021/acs.jmedchem.2c00539.